News
What you need to know about Moderna’s new COVID vaccine, just approved by the FDA
Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID vaccine, but only for specific populations: all adults 65 and over and those between 12 and 64 with at least one underlying risk factor as defined by the Centers for Disease Control and Prevention.
Moderna in January was awarded $590 million ... The Trump administration also fired Food and Drug Administration employees responsible for managing the federal government's response to bird ...
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback